Related Topics News -

     
 < Previous page   Detail   |   Print 
     
《公司業績》邁博藥業(02181HK)中期虧損收窄至1億人民幣
2023-08-27T  
先聲藥業獲邁博藥業-B治療直腸癌藥物內地獨家商業權
2023-08-21T  
恆指急挫逾500點 醫藥股普遍捱沽 榮昌及諾輝健康挫14%至18%
2023-08-02T  
邁博藥業治療哮喘新藥上市註冊申請獲批
2023-05-24T  
邁博藥業向濟民可信授出CMAB007中國獨家推廣權
2023-04-13T  
《公司業績》邁博藥業全年虧損收窄至2.11億人民幣
2023-03-25T  
邁博藥業治療直腸癌核心產品上市註冊申請獲受理
2023-03-15T  
《公司業績》邁博藥業-B半年虧損收窄至1.17億元人民幣
2022-08-26T  
邁博藥業-B銀屑病藥物臨床試驗申請獲中國藥監局批准
2022-07-27T  
 < Previous page 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2026 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.